Laser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia.
Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients.
Zhu said laser scleral microporation preserves patients’ distance visual acuity while restoring their dynamic range of focus.
“I think it’s critical because we’re treating the underlying issue,” Zhu said. “The fact that this can be done bilaterally, can be titrated to each patient and their presbyopia needs, and may even be repeatable in the future, I think it’s going to a game changer for refractive surgery.”
Explore More Articles
Dynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read moreARVO LIVE: AI revolution in ophthalmology
Ophthalmology Times® talked with AnnMarie Hipsley, DPT, PhD, about 3D finite element model used to understand more about the biomechanics of accommodation and dis-accommodation as it relates to functions for visual function as well as aqueous hydrodynamics at this year’s ARVO meeting.
read more